- Home
- CCCC vs NECB Comparison
CCCC vs NECB Comparison
Compare CCCC & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCCC | NECB |
|---|---|---|
| Founded | 2015 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.3M | 282.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCCC | NECB |
|---|---|---|
| Price | $2.44 | $23.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 51.8K |
| Earning Date | 11-06-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 4.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.21 |
| Revenue | $30,108,000.00 | ★ $102,569,000.00 |
| Revenue This Year | N/A | $1.90 |
| Revenue Next Year | N/A | $6.93 |
| P/E Ratio | ★ N/A | $7.26 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $19.27 |
| 52 Week High | $4.70 | $28.92 |
Technical Indicators
Market Signals| Indicator | CCCC | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 46.45 | 71.09 |
| Support Level | $2.50 | $21.30 |
| Resistance Level | $2.69 | $24.08 |
| Average True Range (ATR) | 0.18 | 0.59 |
| MACD | -0.02 | 0.23 |
| Stochastic Oscillator | 7.93 | 80.00 |
Price Performance
Historical ComparisonAbout CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.